Clinical Trial Update: Evaluation of The Vaginal Renewal™ Program in Gynecologic Cancer Patients Experiencing Sexual Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the Vaginal Renewal Program for sexual dysfunction in gynecologic cancer patients has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sexual Dysfunction in Gynecologic Cancer Patients

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Sexual Dysfunction, Physiological | Phase 2 | Status: TERMINATED | Results posted: 2017-07-27